Government Funding
Featured Topics in Life Sciences: Gene Therapy | Vaccines | Government Funding | Genomics & Proteomics | Surgical Devices | all topics
Filter by: News | Articles | New to Market | Tools & Technology | Videos | Podcasts | Journal Articles | White Papers
Jan 26 | News
The
pharmaceutical industry won approval to market a record number of new
drugs for rare diseases last year, as a combination of scientific
innovation and business opportunity spurred new treatments for diseases
long-ignored by drug companies. Many of these so-called orphan drugs
offer extra patent protections and faster government approval.
12/16/2011 | Featured Articles
The life science segment includes diverse firms such as multinational
pharmaceutical corporations, large medical device and instrument
companies, and both large and small biotechnology firms. Though
primarily engaged in human health care, firms in this segment are also
involved in animal health and agricultural biosciences, and many operate
in multiple areas.
12/15/2010 | Featured Articles
The life sciences segment covers the full range of related industries, ranging from pharmaceuticals to medical devices and equipment to biotechnology. While merger and acquisition activity has abated somewhat, it continues to be a defining factor in R&D investment.
1/22/2010 | News
A sealant inspired by mussels' ability to stick to surfaces under wet conditions has shown promise in the repair of defects in human fetal membranes, according to a recent Northwestern Univ. study.
12/8/2009 | News
One of the promises of nanomedicine is the design of tiny particles that can home in on diseased cells and get inside them. Nanoparticles can carry drugs into cells and tag cells for MRI and other diagnostic tests; and they may eventually even enter a cell's nucleus to repair damaged genes. Unfortunately, designing them involves as much luck as engineering.
12/7/2009 | News
Our eyes would tell us that funding for medical research finds itself now at a kind of triple witching hour. Financial, political and social assumptions that have held sway for the last half century are expiring simultaneously and the world economy is in a deep recession. Biomedical investigators are left wondering where new funding will come from in a financial system that may be years in recovery.
11/18/2009 | News
Technological advances in high-throughput DNA sequencing have opened up the possibility of determining how living things are related by analyzing the ways in which their genes have been rearranged on chromosomes. However, inferring such evolutionary relationships from rearrangement events is computationally intensive on even the most advanced computing systems available today. Research recently funded by the American Recovery and Reinvestment Act of 2009 aims to develop computational tools that will utilize next-generation petascale computers to understand genomic evolution.
6/9/2009 | Featured Articles
A recession, stimulus, new administration, continuing resolutions, and globalization effects have altered the picture of R&D spending from just six months ago.
